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When the Going Gets Weird, The 
Weird Turn Pro*: Management Best 
Practices in the Age of Medicinal 
Marijuana   
John I. Winn, JD, LLM** 
Although marijuana remains a prohibited Schedule-I narcotic1 
drug under federal law, so-called “medicinal”2 marijuana is legal in 
thirty-three states and the District of Columbia.  Eleven states and 
* HUNTER S. THOMPSON, FEAR AND LOATHING IN LAS VEGAS: A SAVAGE 
JOURNEY TO THE HEART OF THE AMERICAN DREAM (1971). 
 **  John Winn (Campbell Law ‘84) is currently Professor of Business Law 
at the Harry F. Byrd, Jr. School of Business (AACSB) at Shenandoah 
University in Winchester, VA.  Mr. Winn is also a retired Army Judge Advocate 
General’s Corp (JAG) Officer.  While on active duty, Mr. Winn was as Associate 
Professor of Law at the United States Military Academy (West Point) and 
Assistant Professor of Criminal Law at The Judge Advocate General’s Legal 
Center and School in Charlottesville, VA. 
1. 21 U.S.C. § 812 (2012).  Other Schedule I drugs include heroin, lysergic
acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (ecstasy), and 
peyote.  Id.  There are some prescription “cannabinoid” drugs on the U.S. 
market.  See infra p. 3.  There are also highly-regulated human-subject clinical 
THC trials requiring the approvals of the National Institute on Drug Abuse 
(NIDA), the Drug Enforcement Agency (DEA), plus “investigational new drug” 
(IND) application and research protocol approval from the Food and Drug 
Administration (FDA).  Marijuana Research with Human Subjects, U.S. FOOD
& DRUG ADMIN., https://www.fda.gov/news-events/public-health-focus/ 
marijuana-research-human-subjects [https://perma.cc/H74E-SHG2] (current 
as of Apr. 2, 2019). 
2. “The term medical marijuana refers to using the whole, unprocessed
marijuana plant or its basic extracts to treat symptoms of illness and other 
conditions.”  What is Medical Marijuana?, NAT’L INST. DRUG ABUSE, 
https://www.drugabuse.gov/publications/drugfacts/marijuana-medicine [https: 
//perma.cc/33BZ-XM4T] (revised July 20, 2019). 
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the District of Columbia have recreational marijuana laws in force.3  
Nevada goes so far as to prohibit most employers from denying 
employment to job applicants submitting positive drug-screens for 
marijuana.4  Several states now require employers to accommodate 
medical cannabis users under disability discrimination laws.5  As 
the number of THC-friendly jurisdictions steadily increase, it 
becomes difficult, if not impossible, to maintain “drug-free 
workplaces.”  Employers with safety-sensitive jobs or deploying 
motor vehicles face “damned if you do, damned if you don’t” trade-
offs: either maintain a safe, drug-free workplace6 to preserve 
insurance coverage and federal contracts, or yield to the inevitable 
and seek practical accommodations for employees using medicinal 
or lawful, recreational THC.  This article reviews the current legal 
environment and proposes management best practices for 
businesses seeking to establish lawful, non-discriminatory 
3. Recreational marijuana is used without medical justification in states
which have decriminalized possession, use, or sale of certain types or amounts 
of THC products.  Currently, the Department of Justice follows guidance from 
the United States Attorney General’s Enforcement Memorandum of January 
4, 2018 regarding prosecutorial enforcement and discretion standards.  See 
Memorandum from Jefferson B. Sessions III, Attorney General, to all United 
States Attorneys, on Marijuana Enforcement (Jan. 4, 2018), https:// 
www.justice.gov/opa/press-release/file/1022196/download [https://perma.cc/ 
Q772-4GLW]. 
4. Assemb. B. 132, 80th Sess. (Nev. 2019) (providing, inter alia, limited
exceptions for EMTs, firefighters, motor-vehicle operators, or safety-related 
positions). 
5. Arizona, Arkansas, Connecticut, Delaware, Illinois, Maine,
Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, 
Oklahoma, Pennsylvania, Rhode Island, and West Virginia currently have 
laws affording some degree of employment protection for medicinal marijuana 
use.  State Laws Protecting Medical Marijuana Patients’ Employment Rights, 
CAL. NORML, https://www.canorml.org/employment/state-laws-protecting-
medical-marijuana-patients-employment-rights/ [https://perma.cc/ZKB6-SE 
PL] (last accessed Nov. 20, 2019); e.g., W. VA. CODE ANN. § 16A-15-4(b)(1) (West 
2019) (“No employer may discharge, threaten, refuse to hire or otherwise 
discriminate or retaliate against an employee regarding an employee’s 
compensation, terms, conditions, location or privileges solely on the basis of 
such employee’s status as an individual who is certified to use medical 
cannabis.”). 
6. Procedures for Transportation Workplace Drug and Alcohol Testing,
49 C.F.R. § 40.23 (2012).  See also Exec. Order No. 12,564, 51 Fed. Reg. 32,889 
(Sept. 17, 1986) (establishing federal government agencies as drug-free 
workplaces).  
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cannabis use policies that will not unduly compromise safety or 
productivity.   
I. BACKGROUND
“Lawful” cannabis use in the American workplace is 
exceedingly complicated.  One source estimates that there are more 
than three million registered medical marijuana users in the 
United States.7  Nevertheless, many private sector employers in 
America still conduct pre-employment drug screening.8  Thirty-five 
percent conduct suspicion-based testing, and fifty-one percent 
conduct post-accident testing.9  Workplace THC policies generally 
depend upon where businesses are located.  Jurisdiction determines 
the rights of employers to fire or discipline workers for lawful 
medicinal use.  However, businesses in all states currently retain 
the right to terminate or discipline workers who use, possess, or are 
impaired by marijuana on premises during work hours.  Although 
most states still allow employers to ban recreational marijuana use 
and to test for pre-employment drug use,10 the lack of uniformity 
across jurisdictions can be bewildering.  Maine restricts most 
employers from pre-employment drug testing and prohibits 
terminating most employees for an initial positive drug test.11  In 
states where medical or recreational marijuana use is legal, testing 
agencies are reporting declines in pre-employment drug testing for 
job applicants, especially for marijuana.12  Simultaneously, positive 
screening results for all recreational drugs are at an all-time high13 
(no pun intended).  
7. Medical Marijuana Patient Numbers, MARIJUANA POL’Y PROJECT,
https://www.mpp.org/issues/medical-marijuana/state-by-state-medical-mariju 
ana-laws/medical-marijuana-patient-numbers/ [https://perma.cc/2RE2-FE5L] 
(last updated July 10, 2019). 
8. SHRM Poll: Half of Employers Performed Drug Tests on Final Job
Candidates, SOC’Y FOR HUMAN RES. MGMT. (Sept. 7, 2011), https://www.shrm. 
org/about-shrm/press-room/press-releases/pages/drugtestingefficacypoll.aspx 
[https://perma.cc/4SW9-MKJD]. 
9. Id.
10. E.g., CAL. HEALTH & SAFETY CODE § 11362.45 (West 2017).
11. 26 ME. STAT. tit. 26, §§ 683, 685 (2017).
12. Jim Reidy & Danna Hewick, Are Employer Drug-Testing Programs
Obsolete? SOC’Y FOR HUMAN RES. MGMT., (May 23, 2018), https://www. 
shrm.org/hr-today/news/hr-magazine/0618/pages/are-employer-drug-testing-
programs-obsolete.aspx [https://perma.cc/NU6H-R8SR]. 
13. Id.
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While private U.S. employers generally are not required to test 
job applicants for illicit drug use, many still do.  Employment drug 
testing is important because workplace drug use has serious 
negative consequences.  The nexus between illicit drug abuse and 
compromised workplace safety, productivity, absenteeism, theft, 
and increased medical costs has been documented for decades.14  
Also, three decades of standardized, non-forensic, drug testing 
makes it almost impossible for otherwise “innocent” applicants to 
be excluded from employment because of a false positive tested by 
certified drug-testing laboratories.15  Despite internet claims of 
false positive test results from substances like ibuprofen, current 
immunoassay screening (EMIT) confirmed by gas-chromatography 
or mass-spectrometry testing is essentially foolproof.16  Where still 
lawful, job applicants should be tested even when there is no reason 
to believe prospective employees have used illegal drugs.   
The Drug-Free Workplace Act of 198817 mandates employers 
receiving federal grants or fulfilling federal contracts to establish 
comprehensive programs to achieve workplaces “essentially free of 
drugs.”18  Recently, opiates have become a major source of overdose 
deaths due to increased prescription and sale.19  Opioid abuse is a 
major factor in declining labor force participation among workers 
ages 25 to 54.20 Deaths from prescription painkillers or street 
14. See Arthur L. Frank, Employee Health, 264 JAMA 1177, 1178–79
(reviewing MARK A. ROTHSTEIN, MEDICAL SCREENING AND THE EMPLOYEE
HEALTH COST CRISIS (1989)). 
15. The Department of Health and Human Services (HHS) certifies
laboratories as “Instrumented Initial Testing Facilities” (IITF) meeting 
Mandatory Guidelines for Federal Workplace Drug Testing Programs.  See 
Mandatory Guidelines for Federal Workplace Drug Testing Programs, 82 Fed. 
Reg. 7920 (Jan. 23, 2017). 
16. See Veronica I. Luzzi et al., Analytic Performance of Immunoassays for
Drugs of Abuse Below Established Cutoff Values, 50 CLINICAL CHEMISTRY, 717, 
720–21 (2004). 
17. See 41 U.S.C. § 8101–8106 (2012).
18. 10 C.F.R. § 707.11 (requiring government contractors to test (at a
minimum) for marijuana, cocaine, opiates, phencyclidine and amphetamines). 
19. See Press Release, Center for Disease Control, March 15, 2016, CDC
Releases Guideline for Prescribing Opioids for Chronic Pain; see also, Michael 
C. Milone, Laboratory Testing for Prescription Opioids, 8 J. MED. TOXICOLOGY
408 (2012).
20. Mamta Badkar, Yellen: Opioid Crisis Weighing on US Labour Force
Participation, FIN. TIMES (July 13, 2017), https://www.ft.com/content/ 
776ba9e3-d47c-3554-8421-9238f79ef1b7 [https://perma.cc/92JX-NPHB]. 
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substitutes have nearly tripled over a fifteen-year span.21  As for 
cannabis use, despite the rapid expansion in lawful use 
jurisdictions, drug testing for THC still matters.22  Marijuana 
remains unlawful under federal law.  Even California’s expansive 
Proposition 64 amendment, which makes recreational marijuana 
use lawful, preserves the employer’s right to maintain strict drug 
and alcohol-free workplaces.23  Use of any psychoactive drug can 
affect work performance even when drug use occurs outside of work 
hours.  Although some employers have relaxed drug-use policies, 
there are compelling reasons to not do so, including safety, 
productivity, Workers’ Compensation coverage, and third-party 
civil liability.24  
Impaired workers expose employers to liability even when 
employees act outside of the normal “scope of their employment.”25  
If an impaired employee acts out and injures fellow workers or third 
21. Rose A. Rudd et al., Increases in Drug and Opioid-Involved Overdose
Deaths—United States, 2010–2015, 65 MORBIDITY MORTALITY WKLY. REP. 1445, 
1445 (2016), https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1. 
htm?s_cid=mm655051e1_w [https://perma.cc/Y69T-GHA8]. 
22. THC is the psychoactive chemical found in the cannabis plant
producing euphoria, elation, delusions, changes in thinking, and even 
hallucinations.  See Zerrin Atakan, Cannabis, a Complex Plant: Different 
Compounds and Different Effects on Individuals, 6 THERAPEUTIC ADVANCES
PSYCHOPHARMACOLOGY 241, 242 (2012). 
23. California’s “Control, Regulate and Tax Adult Use of Marijuana Act”
states: 
Nothing in section 11362.1 shall be construed or interpreted to amend, 
repeal, affect, restrict, or preempt:  
. . . 
(f) The rights and obligations of public and private employers to
maintain a drug and alcohol free workplace or require an employer to
permit or accommodate the use, consumption, possession, transfer,
display, transportation, sale, or growth of marijuana in the work
place, or affect the ability of employers to have policies prohibiting the
use of marijuana by employees and prospective employees, or prevent
employers from complying with state or federal law.
CAL. HEALTH & SAFETY CODE § 11362.45 (West 2017). 
24. See Steve Bates, Rethinking Zero Tolerance on Drugs in the Workplace,
SOC’Y FOR HUM. RESOURCES MGMT., (December 5, 2017), https://www.shrm. 
org/resourcesandtools/hr-topics/talent-acquisition/pages/rethinking-zero-toler 
ance-drugs-workplace.aspx [https://perma.cc/6BVD-M243]. 
25. See George Fitting, Careless Conflicts: Medical Marijuana
Implications for Employer Liability in the Wake of Vialpando v. Ben’s 
Automotive Services, 102 IOWA L. REV. 259, 271 (2018). 
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parties, employers can be sued for negligent hiring or retention.26  
Although employees using marijuana off duty may not feel high or 
be noticeably impaired, there is evidence that THC metabolites are 
not fully metabolized for days and sometimes even weeks after use, 
especially among chronic THC users.27  There is little doubt that if 
polled, most people would prefer to not be under the care of a nurse 
whose judgment is even slightly impaired by THC.  Would a 
commercial pilot feel comfortable knowing her aircraft was being 
serviced or inspected by a recreational drug user?  One CEO states 
that, “[i]f you’re in the construction industry, marijuana use is not 
acceptable at any time, under any circumstance or condition.”28 
II. MEDICINAL MARIJUANA
The two most recognized compounds found in the cannabis 
plant, from which marijuana is derived, are Tetrahydro-Cannabinol 
(THC), which has a psychotropic effect, and Cannabidiol (CBD), 
which has no psychotropic effect.29  The Food and Drug 
Administration (FDA) has approved the use of therapeutic 
medicines containing THC or CBD in a limited number of 
circumstances, such as the drug Epidiolex, which contains CBD, for 
the treatment of seizures associated with Lennox-Gastaut 
syndrome or Dravet syndrome.30 Additionally, two drugs 
containing a synthetic form of THC—Marinol and Syndros—have 
been approved by the FDA to reduce anorexia that sometimes 
occurs in tandem with treatment for AIDS, along with Cesamet, 
which also contains synthetic THC.31  There are, however, data 
26. See Elliot S. Kaplan et al., Drug and Alcohol Testing in the Workplace:
The Employers’ Perspective, 14 WM. MITCHELL L. REV. 365, 372 (1988). 
27. See Robert S. Goodwin et al., Urinary Elimination of 11-Nor-9-
Carboxy-∆9- Tetrahydrocannnabinol in Cannabis Users During Continuously 
Monitored Abstinence, 32 J. ANALYTICAL TOXICOLOGY, 562 (2008). 
28. Drug Use a Problem for Employers, GAZETTE, (Mar. 24, 2015),
https://gazette.com/news/drug-use-a-problem-for-employers/article_ab53e66f-
4923-55a5-a48c-00b05cf262f9.html [https://perma.cc/NRU4-CCMS]. 
29. Atakan, supra note 22, at 245–46.
30. FDA Regulation of Cannabis and Cannabis-Derived Products,
Including Cannabidiol (CBD), U.S. FOOD & DRUG ADMIN., 
https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-
and-cannabis-derived-products-including-cannabidiol-cbd#approved [https:// 
perma.cc/N6BX-K3VF] (last updated Jan. 15, 2020) [hereinafter, FDA 
Regulation of Cannabis]. 
31. Id.
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suggesting that marijuana or compounds found in marijuana may 
help relieve certain types of pain, nausea, glaucoma, lupus, 
multiple sclerosis, depression, and other conditions.32 A 
shortcoming of most of these trials is that the National Institute of 
Health (NIH) approved research on marijuana therapies that focus 
upon specific cannabinoid chemicals, or group of chemical 
compounds.33  Therapeutic effects are difficult to determine 
because most trials lack appropriate control groups and long-term 
follow-up, or use inadequate sampling sizes.34 Tests involving 
double-blind testing using smoked marijuana leaves have not 
produced consistent or measurable outcomes.35 
While risks from side effects and psychoactive properties of 
marijuana are usually mild compared to alcohol or other drugs, 
there is no formal pharmacological regulation of ‘lawful’ cannabis 
products.  Composition and quality of THC and CBD products are 
typically not guaranteed.  Dosages vary widely from one study to 
the next (as does observed effectiveness from participating subject 
to subject).36  What remains unchallenged is that inhaled Cannabis 
smoke has well-documented harmful effects upon the lungs.37  In 
addition to THC and CBD, marijuana products contain literally 
hundreds of other chemicals.  Measured potencies of THC content 
in marijuana have also increased substantially over the past thirty 
years; from roughly 2% THC in 1980 up to 15-20% THC in more 
recent studies.38  Despite growing public acceptance, there are no 
recognized medical conditions in which marijuana-based therapy is 
a first-line clinically approved treatment.  
32. See NAT’L ACAD. OF SCI., ENG’G, & MED., THE HEALTH EFFECTS OF
CANNABIS AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND
RECOMMENDATIONS FOR RESEARCH, 87 (Nat’l Acad. Press 2017). 
33. See generally id. at 377–90 (challenges include regulatory, financial,
and access barriers, limited funding and supply, and lack of standardized 
procedure). 
34. Id.
35. See id. at 386–87.
36. See id. at 254.
37. Donald P. Tashkin, Effects of Marijuana Smoking on the Lung, 10 AM. 
THORACIC SOC’Y, Feb. 2013, at 239, 239–40. 
38. WORLD HEALTH ORG., THE HEALTH AND SOCIAL EFFECTS OF NONMEDICAL
CANNABIS USE, 3–4, (2016). 
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Along with medicinal-THC, there has been a major upsurge in 
the popularity of transdermal CBD oils and lotions.39  CBD 
products, derived from low-THC industrial hemp plants, are 
marketed over the counter as treatment for arthritis, anxiety, 
depression, and numerous other conditions.40  The FDA does not 
regulate CBD because it is classified as a “hemp-plant-based-
supplement” and not a drug.41  Like medicinal THC, however, there 
are no established standards for dosage, purity, efficacy, or safety 
for CBD, except that CBD supplements may not be comprised of 
more than 0.3% THC to be classified as a “hemp-product”.  The DEA 
opines that  
for practical purposes, all extracts that contain CBD will 
also contain at least small amounts of other cannabinoids 
. . . . Although it might be theoretically possible to produce 
a CBD extract that contains absolutely no amounts of other 
cannabinoids, the DEA is not aware of any industrially-
utilized methods that have achieved this result.42   
Although CBD products should not result in impairment or 
trigger a positive THC drug screen, a recent study found that many 
CBD products were mislabeled as to CBD content.43  More 
troublesome was that the study also found THC in 18 of 84 CBD 
products purchased online.44  
39. Cannabidiol, more commonly referred to as CBD, is a
“phytocannabinoid derived from Cannabis species, which is devoid of 
psychoactive activity, with analgesic, anti-inflammatory, antineoplastic and 
chemopreventive activities.” Cannabidiol, NAT’L CANCER INST.:
NCITHESAURUS, https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?diction 
ary=NCI_Thesaurus&ns=ncit&code=C118452 [https://perma.cc/PW55-Q5H6] 
(last visited on Jan. 25, 2020).  
40. See FDA Regulation of Cannabis, supra note 30.
41. See id.
42. Establishment of a New Drug Code for Marihuana Extract, 81 Fed.
Reg. 90194, 90195 & n.1 (Dec. 14, 2016) (to be codified at 21 C.F.R. pt. 1308). 
43. Marcel O. Bonn-Miller, et al., Research Letter: Labeling Accuracy of
Cannabidiol Extracts Sold Online, 318 JAMA 1708, 1709 (2017). 
44. Id. at 1708–09.
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III. AMERICANS WITH DISABILITIES ACT AND FAMILY AND MEDICAL
LEAVE ACT 
With limited exceptions, noted below, because marijuana 
remains a “Schedule I” drug, courts have held employers are not 
required to accommodate medical marijuana under the Americans 
with Disabilities Act (ADA) in states that allow medical marijuana 
use.45  Nevertheless, employees lawfully using medicinal 
marijuana may seek unpaid time-off under the Family and Medical 
Leave Act (FMLA)46 or request medical leave under the ADA.47  
The ADA and FMLA often overlap in coverage.  For example, an 
employee with a “serious health condition” under the FMLA may 
simultaneously have a qualifying “disability” under the ADA. 
Under FMLA, the maximum allowable term of usable leave is 
twelve weeks within a twelve month period.48  The ADA does not 
limit the amount of leave an employee is allowed, so long as it is a 
“reasonable accommodation” that does not cause the employer 
“undue hardship.”49  FMLA leave can run concurrently with paid 
time off, including sick-leave or vacation leave.50  Under the ADA, 
however, all other leave to which the employee is entitled must be 
exhausted before ADA leave applies.51 
45. See James v. City of Costa Mesa, 700 F.3d 394, 405 (9th Cir. 2012).
But see Noffsinger v. SSC Niantic Operating Company, LLC, 273 F. Supp. 3d 
326, 337–38 (D. Conn. 2017) (holding that federal law does not preempt the 
state’s palliative marijuana statute prohibiting (most) employers from hiring 
qualified applicants who may be medical marijuana users). 
46. 29 U.S.C. §§ 2601–2654 (2012).
47. 42 U.S.C. §§ 12101–12213 (2012).
48. 29 U.S.C. § 2612(a)(1).
49. 29 C.F.R. § 825.702(b) (2018).  Indefinite leave has not been considered
a “reasonable accommodation” by many courts that have considered the issue 
because it often causes the employer “undue hardship.”  Stephen F. Befort, The 
Most Difficult ADA Reasonable Accommodation Issues: Reassignment and 
Leave of Absence, 37 WAKE FOREST L. REV. 439, 463 (2002). 
50. 29 C.F.R. § 825.207(a).  See also U.S. DEP’T OF LABOR, WAGE & HOUR
DIV., FACT SHEET #28: THE FAMILY AND MEDICAL LEAVE ACT 2 (2012), 
https://www.dol.gov/whd/regs/compliance/whdfs28.pdf [https://perma.cc/BS7D 
-ZM77].
51. See U.S. EQUAL OPPORTUNITY EMP’T COMM’N, EMPLOYER-PROVIDED
LEAVE AND THE AMERICANS WITH DISABILITIES ACT 2–3 (2016),
https://www.eeoc.gov/eeoc/publications/upload/ada-leave.pdf [https://perma.cc/
9GAE-UT57].
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The FMLA requires employees to share patient medical 
information with the employer in order to certify that a “serious 
medical condition” exists.52  Medical inquiries under the ADA, on 
the other hand, are strictly limited to disability-related inquiries 
which are “job-related and consistent with business necessity.”53  In 
other words, medical inquiries by employers under the ADA are 
used only to determine if an ADA qualifying disability exists or how 
the employer can “reasonably accommodate” the employee.54  In 
some locations, medical marijuana might be prescribed by a 
physician (or other healthcare provider) for treatment of a medical 
condition that is a recognized “disability” under the ADA55 despite 
the fact that the ADA expressly excludes from its coverage “any 
employee or applicant who is currently engaging in the illegal use 
of drugs.”56   
For medicinal marijuana use, several states, including 
Arizona, Illinois, and Delaware, prohibit terminating employees 
lawfully using therapeutic marijuana without proof of on-the-job 
impairment.57  In other states, such as Minnesota and Nevada, 
employers may not terminate medical marijuana users unless (1) 
the employee displays on-the-job impairment, (2) not taking 
disciplinary action violates applicable federal regulations, or (3) it 
would result in the loss of a federal contract, federal licensure, or 
related federal benefits.58  Some states without specific statutory 
52. 29 C.F.R. § 825.305(a).
53. U.S. EQUAL OPPORTUNITY EMP’T COMM’N, NOTICE NO. 915.002, 
ENFORCEMENT GUIDANCE: DISABILITY-RELATED INQUIRIES AND MEDICAL
EXAMINATIONS OF EMPLOYEES UNDER THE AMERICANS WITH DISABILITIES ACT
(ADA) (2000), https://www.eeoc.gov/policy/docs/guidance-inquiries.html [https: 
//perma.cc/9MKX-AC7W] [hereinafter U.S. EQUAL OPPORTUNITY EMP’T
COMM’N]. 
54. Id.
55. Medical use for an ADA-recognized disability qualifying medical
condition should be distinguished from “drug addiction” (or alcohol 
dependency) which has been recognized as a qualifying disability under the 
ADA.  See Alexander v. Washington Metro. Area Transit Auth., 826 F.3d 544, 
550 (D.C. Cir. 2016) (quoting 29 C.F.R. 1630.2(j)(1)(ii)); Mauerhan v. Wagner 
Co., 649 F.3d 1180, 1185 (10th Cir. 2011) (quoting Nielsen v. Moroni Feed Co., 
162 F.3d 604, 609 (10th Cir. 1998)). 
56. 42 U.S.C. § 12114(a) (2012); 29 C.F.R. § 1630.3(a) (2018).
57. See Sachi Barreiro, State Laws on Off-Duty Marijuana Use, NOLO
https://www.nolo.com/legal-encyclopedia/state-laws-on-off-duty-marijuana-
use.html [https://perma.cc/94J9-WNSB] (last visited Jan. 25, 2020). 
58. Id.
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guidance, including Oregon,59 Colorado,60 and California61 have 
upheld the rights of employers to terminate employees for medical 
cannabis use, even those with legitimate medical conditions.  In 
Barbuto v. Advantage Sales and Marketing, LLC, however, the 
Massachusetts Supreme Judicial Court held that “the use and 
possession of medically prescribed marijuana by a qualifying 
patient is as lawful as the use and possession of any other 
prescribed medication.”62  The court further held that employers 
must provide “reasonable accommodation” for medicinal use of THC 
unless the accommodation resulted in undue hardship for the 
employer.63  It is important to note that Barbuto involved medicinal 
marijuana use during off-duty hours without workplace 
impairment in a non-safety-sensitive position.64 
In a similar case, Callaghan v. Darlington Fabrics, a Rhode 
Island trial court ruled the employer discriminated against the 
employee under the state medical marijuana law by refusing to 
employ an applicant holding a state medical marijuana therapy 
card.65  The court in Callaghan held that the applicant’s 
prescription card put the employer on notice that the applicant had 
a qualifying disability under Rhode Island law.66  Under those 
circumstances, the employer was obligated to determine if any 
reasonable accommodation for the prospective employee was 
feasible.67   
In Noffsinger v. SSC Niantic Operating Co. LLC, the United 
States District Court for the District of Connecticut ruled that the 
ADA does not preempt Connecticut state law because the ADA was 
not intended to preempt state antidiscrimination laws affording 
greater anti-discrimination protections.68  Noffsinger represents 
the first federal court ruling recognizing that the federal Controlled 
59. Emerald Steel Fabricators, Inc. v. Bureau of Labor and Indus., 230
P.3d 518, 520 (Or. 2010).
60. See Coats v. Dish Network, LLC, 350 P.3d 849, 850 (Colo. 2015).
61. Ross v. RagingWire Telecomms., Inc., 174 P.3d 200, 203 (Cal. 2008).
62. 78 N.E.3d 37, 45 (Mass. 2017).
63. Id. at 43.
64. See id. at 41.
65. No. PC-2014-5680, 2017 WL 2321181, at *10 (R.I. Super. May 23,
2017). 
66. Id. at *11.
67. Id. at *13.
68. 273 F. Supp. 3d 326, 338 (D. Conn. 2017).
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Substances Act does not preempt state anti-discrimination 
provisions favoring medical marijuana users denied employment 
after testing positive for marijuana.69  The judge in Noffsinger did 
take pains to point out that the facts of the case did not involve 
workplace drug use and that the Connecticut Palliative Use statute 
expressly declines to sanction workplace cannabis use.70   
Under the ADA, employers should generally avoid asking 
applicants about lawful drug use, as inquiries of this type may tend 
to elicit personal information about a qualifying disability.71  On 
the other hand, if an employee or job applicant tests positive for 
THC, employers may lawfully ask for an explanation for the 
positive result.72  Whether or not a business is located in a state 
recognizing medicinal THC use, workplace disciplinary actions in 
which an employee claims lawful “medical cannabis” as justification 
or excuse for the behavior becomes a bit more complicated.  In such 
cases, the best practice for management is focusing upon actual 
documented “misconduct.”  In other words, the issue is not whether 
the employee used medicinal marijuana.  The issue is whether the 
employee has been chronically late for work.  Focusing inquiries 
away from claimed medical conditions helps prevent claims that 
proposed disciplinary action is merely “pretextual” discrimination 
based upon an otherwise qualifying ADA-disability.  Although 
medical marijuana users are never entitled to a “free pass,” in 
EEOC v. Pines of Clarkston, a federal district court denied a motion 
for summary judgment by the employer after concluding that a jury 
could have determined the actual reason for terminating the 
employee was the employee’s epilepsy, a protected disability, rather 
than a positive drug test.73   
IV. IMPAIRMENT TESTING AND WORKERS’ COMPENSATION
Scientific “testing” for measuring actual THC-induced 
impairment via blood, breath, or urine is currently not possible in 
light of individual drug tolerance levels, different strains of 
69. Id. at 334.
70. Id. at 337 (citing CONN. GEN. STAT. §§ 21a–408(b)(2)–(3)).
71. U.S. EQUAL OPPORTUNITY EMP’T COMM’N, supra note 53.
72. See id.
73. No. 13-CV-14076, 2015 WL 1951945, at *7 (E.D. Mich. Apr. 29, 2015).
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marijuana, varying forms of ingestion, and frequency of use.74  
Although employers retain the right to discipline employees 
violating workplace drug use in all jurisdictions, it can be difficult 
to prove actual workplace consumption since drug testing cannot 
determine where or when marijuana was ingested.  Disciplinary 
action against employees is authorized even if the employee’s drug 
use is connected to treatment for a disability.75 Although 
Colorado76 and Washington77 have enacted statutes allowing an 
inference of impairment with a measured THC blood level of five 
ng/ml or higher, there are currently no generally accepted 
standards as to what constitutes THC impairment.78  Reductions 
in motor skills, except in gross impairment situations, are generally 
not measurable by standardized neurocognitive tests.79  One study 
points out a problematic “all or none” scenario in which THC 
patients receive either a “sub-therapeutic” effect or are dosed past 
the point of impairment.80  In another study, THC content of 
marijuana products varied from package labeling by over 40%.81  
74. Hallvard Gjerde et al., Evaluation of Dräger DrugTest 5000 in a
Naturalistic Setting, 42 J. ANALYTICAL TOXICOLOGY 248, 248–49 (2018). 
75. The Americans With Disabilities Act: Applying Performance And
Conduct Standards To Employees With Disabilities, U.S. EQUAL EMP.
OPPORTUNITY COMMISSION, http://www.eeoc.gov/facts/performance-conduct. 
html [https://perma.cc/K66B-CDYF] (last modified Dec. 20, 2017). 
76. COLO. REV. STAT. § 42–4–1301(6)(a)(IV) (2016).
77. WASH. REV. CODE § 46.61.506(1) (2013).
78. The Government Accountability Office (GAO) reported in 2015 that
“identifying a link between impairment and drug concentrations in the body, 
similar to the 0.08 BAC threshold established for alcohol, is complex and, 
according to officials from the Society of Forensic Toxicologists, possibly 
infeasible.”  U.S. GOV’T ACCOUNTABILITY OFFICE, DRUG IMPAIRED DRIVING:
ADDITIONAL SUPPORT NEEDED FOR PUBLIC AWARENESS INITIATIVES 15 (2015), 
https://www.gao.gov/products/GAO-15-293?source=ra [https://perma.cc/H25D-
6KDA].  Hound Laboratories, Inc. claims to have developed a reliable “Pot 
Breathalyzer” which is capable of measuring THC-levels in exhaled breath 
correlating to impairment; the device has not been approved for law 
enforcement use by any agency at the time of this writing.  See Eric Westervelt, 
The Pot Breathalyzer is Here.  Maybe., NAT’L PUB. RADIO (Aug. 4, 2018 8:02 
AM), https://www.npr.org/2018/08/04/634992695/the-pot-breathalyzer-is-here-
maybe [https://perma.cc/89AM-Y3GU]. 
79. Robert S. Goldsmith et al., Medical Marijuana in the Workplace:
Challenges and Management Options for Occupational Physicians, 57 J. 
OCCUPATIONAL & ENVTL. MED. 518, 522 (2015). 
80. Id.
81. Id.
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Synthetic cannabinoids are also available and pose unique testing 
problems.  Substances such as “K2” and “Spice” may cause severe 
impairment but most workplace drug screening (EMIT) tests do not 
detect synthetic THC analogues.82  Testing for synthetic drugs is 
significantly more expensive than THC-screening and constantly 
changing chemical compositions make detection impracticable.83  
Presently, urine is the most tested sampling matrix, but blood, 
saliva, hair, and even breath samples may be utilized.84  Non-
chemical “interactive” impairment testing methods typically 
measure physical reaction times to a signaled “que” and are 
currently being marketed to test general workplace fitness for 
duty.85  Some interactive or instrument impairment testing 
involves measuring hand-eye motor skills as employees manipulate 
a cursor in a video simulation.86  Other tests utilize eyepiece 
scanners to measure ocular response times and compares the 
results to previous “baseline” tests.87  Computer algorithms 
calculate impairment scores and provide alerts when test-takers 
are potentially impaired.88  Although chemical testing is advised 
whenever an employee “fails” a machine-based impairment test, 
interactive testing has no delay time awaiting urine or blood 
tests.89  Employees should always be removed from dangerous 
duties or be sent home to ensure safety is not compromised. 
Interactive testing can also identify non-drug-related impairments 
such as fatigue, alcohol, prescription drugs, or illness.90   
82. See Ken Kulig, Interpretation of Workplace Tests for Cannabinoids, 13
J. MED. TOXICOLOGY 106, 110 (2016).
83. Id.
84. Id. at 106; Kara L. Lynch et al., Correlation of Breath and Blood Δ9-
Tetrahydrocannabinol Concentrations and Release Kinetics Following 
Controlled Administration of Smoked Cannabis, 65 CLINICAL CHEMISTRY 1171,
1171 (2019).  THC levels of self-reported volunteer marijuana users were 
measured through breath samples; the study found detectable levels of THC 
in breath samples up to three hours after ingestion.  Lynch, supra, at 1171.  
85. Evelyn Beck, Is the Time Right for Impairment Testing, WORKFORCE
(Feb. 1, 2001), https://www.workforce.com/2001/02/01/is-the-time-right-for-
impairment-testing/ [https://perma.cc/R3AA-WYZY].  
86. Id.
87. Id.
88. Id.
89. Id.
90. Id.
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THC has well-documented effects upon depth perception, 
reaction time, and coordination.91  Research on the psychomotor 
and judgment effects of marijuana ingestion demonstrate an 
increased risk for fatal motor vehicle accidents.92  Postal workers 
who tested positive for marijuana had 55% more accidents, 85% 
more injuries, and 78% greater absenteeism.93  One can probably 
assume that in higher dosages, THC may create significant sensory 
distortion.  Although at least one study found that marijuana 
ingestion by experienced users had only modest effects upon 
complex task performance,94 the use of THC is totally incompatible 
with someone working in a safety-sensitive position.  Safety, 
however, is far from the only consideration.  Attention to detail 
remains important even in office environments.  A misplaced digit 
or failure to recognize a phony email address could cost a business 
thousands of dollars.95  No one would ever claim that marijuana 
use reduces the frequency of workplace accidents or mistakes.  
Considering the variables in dosages and effects on individual 
users, it is not feasible to ensure industrial workplace safety if 
workers use marijuana.  Under OSHA regulations, employers may 
not create conditions endangering safety and health in the 
workplace and must ensure that workplaces are essentially “free 
from serious recognized hazards.”96  In safety-sensitive positions, 
this means “zero tolerance” for illicit drug use should remain in 
91. Rebecca L. Hartman & Marilyn A. Huestis, Cannabis Effects on
Driving Skills, 59 CLINICAL CHEMISTRY 478, 479 (2013). 
92. Mark Asbridge et al., Acute Cannabis Consumption and Motor Vehicle
Collision Risk: Systematic Review of Observational Studies and Meta-analysis, 
344 BRIT. MED. J., Feb. 6–12, 2012. https://www.bmj.com/content/bmj/ 
344/bmj.e536.full.pdf [https://perma.cc/RZ2W-HUA4]. 
93. Craig Zwerling et al., The Efficacy of Preemployment Drug Screening
for Marijuana and Cocaine in Predicting Employment Outcome, 264 JAMA 
2639, 2643 (1990).  
94. See Carl L. Hart et al., Effects of Acute Smoked Marijuana on Complex
Cognitive Performance, 25 NEUROPSYCHOPHARMACOLOGY 757, 764 (2001). 
95. The North Carolina State Bar Journal recently noted an incident in
which a law firm was defrauded of over $300,000 when an employee (albeit 
with no evidence of drug use) inadvertently failed to notice an email address 
in which an “I” was replaced by the number “1.”  See Leanor Bailey Hodge, 
Mark the Rea1Estate Guy, N.C. ST. B.J., Spring 2019, 25, 25, 31. 
96. Occupational Health and Safety Admin., Employer Responsibilities,
U.S. DEP’T LAB, https://www.osha.gov/as/opa/worker/employer-
responsibility.html [https://perma.cc/SU64-LUNA] (last visited Nov. 30, 2019).
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place and be enforced even if other employees are simultaneously 
allowed to use medicinal or recreational cannabis.  
V. SUMMARY
In states with liberal recreational use laws, finding qualified 
workers may be a challenge.  While a complete prohibition of 
marijuana on or off duty is a responsible and logical standard, in 
some jurisdictions off-duty bans are no longer feasible.  In some 
states, bans on THC use in general may lead to discrimination 
claims under the ADA, state disability, or therapeutic use laws. 
Medical cannabis may have potential benefits for employees, while 
lawful off-duty recreational THC use by employees holding non-
critical and non-safety-sensitive jobs may be compatible for some 
businesses.  No employer, however, should lose sight of the fact that 
THC in the workplace always carries some risk to safety, 
productivity, liability, and worker health.  Until the right to 
maintain a drug-free workplace is modified by state or federal laws, 
many employers will not find an advantage (other than expediency) 
in hiring employees using medical or recreational THC.  Costs, 
benefits, and risks must be carefully evaluated.   
In states where medical THC is already a reality, employer 
cannabis policies should be carefully tailored for each workplace 
and each unique job position.  As legal landscapes shift, managers 
should work closely with human resources (HR) and legal 
professionals to implement clear, workable, and up-to-date policies. 
In addition, assistance from an employment lawyer and 
occupational health specialist may be necessary to maintain full 
compliance with state laws and federal mandates.  Given the rapid 
evolution of both THC legislation and case law, cannabis policies 
should be reviewed and updated annually to reflect current law and 
best practices.  HR should remain primarily responsible for 
ensuring screening and use policies are consistent across 
departments because most HR departments are already familiar 
with drug testing.  Managers should be trained to be fair and 
consistent in the enforcement of these policies.97  Intervention 
97. For an excellent resource for managers to evaluate impartment issues,
see generally FIRST LAB INC., A SUPERVISOR’S MANUAL: GUIDELINES FOR
REASONABLE SUSPICION DRUG AND ALCOHOL TESTING (Nov. 2002), 
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support should always be available for employees with substance 
abuse problems.  Continuous commitment is essential in 
maintaining safe workplace standards, especially if policies create 
separate “THC allowed” and “THC forbidden” worker subsets.  The 
following best practices may be worthy of consideration in 
formulating workplace cannabis-use policies.   
VI. SUGGESTED BEST PRACTICES
The first best practice would be for businesses developing 
medicinal (or lawful recreational) use policies to evaluate whether 
medicinal cannabis use is compatible with the duties and 
responsibilities of each job position.  For example, lawful use may 
not affect housekeeping staff, but accommodating marijuana use for 
delivery drivers poses significant safety and liability risks.   
A second suggested best practice would be to require self-
reporting medicinal-use employees (or applicants) to complete ADA 
accommodation request forms.  Employees should certify medical 
use is a necessary accommodation under applicable state law.  All 
employees should affirm they will not use or possess cannabis 
products at work or share cannabis with other employees.  Policies 
must clearly indicate that workplace impairment is unacceptable 
and will result in termination or other discipline.   
Businesses may choose to discontinue THC testing completely 
or limit testing to safety-related positions.  Employers choosing the 
latter course of action should retain the right to drug test employees 
following workplace accidents or when there is a reasonable 
suspicion of on-the-job impairment.98  Non-THC-specific workplace 
impairment policies should specify broadly and generally what 
constitutes unacceptable conduct.  Disciplining or terminating an 
employee for clearly observed and documented impaired behavior 
is less complicated than discipline for a positive drug-screen 
following reported suspicion of drug use.  Bear in mind that ng/ml 
levels in chemical screening tests are not reliable indicators of 
http://ppta.net/pdf/ReasonableSuspicionTestingSupervisorManual%20.pdf 
[https://perma.cc/F3SG-SXKM]. 
98. See, e.g., 21 R.I. GEN. LAWS § 21–28.6–4(e) (1956) (allowing employers
to refuse employment where marijuana use would affect workplace safety).  In 
Rhode Island, employees must be provided copies of positive drug test results 
and opportunities to challenge the testing, explain results, or request sample 
re-testing.  28 R.I. GEN. LAWS § 28–6.5–1. 
2020] EMPLOYMENT LAW 77 
impairment.  Employers should still reserve the right to test urine 
or blood for high ng/ml levels as one of several factors in 
determining impairment following observed impaired behavior. 
Additionally, if an applicant that is a lawful medical marijuana 
user with a claimed ADA-qualifying medical condition is denied 
employment for reasons not related to medicinal use, the employer 
policies should dictate that management documents exactly why 
the applicant was not qualified, was not the best candidate, or could 
not be reasonably accommodated.  To avoid claims of pretextual 
discrimination,99 documentation should address why a claimed 
disability was not a factor in denying employment or that 
reasonable accommodation was not feasible.  Medical use policies 
in federally regulated workplaces and industries should clearly 
state that in the event of conflicts between local, state, and federal 
law, federal drug-free workplace regulations may overrule state 
medicinal THC protections.  Further, after reported misconduct, an 
employee might claim the workplace policy violation arose from an 
ADA-recognized disability and request accommodation.  If 
misconduct is serious enough to warrant termination, no 
accommodation discussion needs to take place.  If proposed 
discipline does not involve termination, the employer should begin 
the “interactive process”100 needed to determine if accommodation 
is feasible.  Further, post-accident testing policies should remain in 
place.  An employer may also consider establishing rules or 
guidelines to follow if an employee is arrested for or convicted of 
impaired (off-duty) driving.  
All requests for employee medical records, employee medical 
questions, or requests for employees to undergo medical 
examinations should be based upon documented necessity per 
FMLA or ADA standards.  Medical inquiries under the ADA must 
be based upon a reasonable belief that the employee’s ability to 
perform an essential job function will be impaired by a “qualifying 
disability” or that performing the task or tasks with the qualifying 
disability poses a direct threat of physical harm to the employee or 
99. See Warshaw v. Concentra Health Servs., 719 F. Supp. 2d 484, 491–92
(E.D. Pa. 2010); see also EEOC v. Pines of Clarkston, No. 13-CV-14076, 2015 
WL 1951945, at *5 (E.D. Mich. Nov. 29, 2015). 
100. See, e.g., McBride v. BIC Consumer Prods. Mfg. Co., 583 F.3d 92, 99–
100 (2d Cir. 2009). 
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others.101  Employers faced with FMLA-related medical issues 
should follow the FMLA “certification” process to determine if the 
employee has a qualifying “serious health condition” that requires 
inpatient care or continuing treatment by a healthcare provider.102  
All medical information provided by employees (or applicants) must 
be treated as confidential medical records.103  These standards 
should apply regardless of whether the applicant or employee is 
seeking a formal accommodation under the ADA or certification 
under the FMLA. 
Managers should remain sensitive to any management 
practices that might result in disparate treatment or disparate 
impact complaints by employees using medical marijuana.  For 
example, if a supervisor knows an employee is a medical marijuana 
cardholder and feels the employee is tardy because of THC yet fails 
to hold other, non-THC-using employees to the same standard, the 
supervisor’s conduct may trigger an ADA or Title VII claim.104  
Where strict “drug free” work safety standards must be 
maintained, consider using non-chemical interactive impairment 
testing equipment.  Ensure impairment policies allow managers to 
remove workers from the jobsite and to test blood or urine following 
any interactive testing result indicative of impairment.  When a 
lawful-use employee shows evidence of on-the-job impairment, the 
employer may elect to provide the employee a “firm choice” between 
Employee Assistance Program (EAP) (or other rehabilitative 
treatment) and termination.105  Effects of cannabis on behavior 
vary from person to person.  Unprofessional workplace behavior 
should never be tolerated.  Drug-free co-workers may resent the 
“freedom” of medicinal users, especially if they are forced to cover 
for the other worker’s absenteeism or lower productivity.  
Employers might also consider a CBD use policy.  Because CBD 
products are unregulated, CBD products containing THC may 
101. U.S. EQUAL OPPORTUNITY EMP’T COMM’N, supra note 53.
102. See U.S. DEP’T OF LAB. WAGE AND HOUR DIVISION, EMPLOYERS GUIDE TO
THE FAMILY AND MEDICAL LEAVE ACT 28, https://www.dol.gov/whd/fmla/ 
employerguide.pdf [https://perma.cc/4JS6-ACFU] (last visited Nov. 27, 2019). 
103. 42 U.S.C. § 12112(d)(3)(B), (4)(C) (2008).
104. See The Americans With Disabilities Act: Applying Performance And
Conduct Standards To Employees With Disabilities, supra note 75. 
105. See Dustin Riddle & Richard Bales, Disability Claims for Alcohol-
Related Misconduct, 82 ST. JOHN’S L. REV. 699, 702 (2008). 
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result in a positive urine drug test.  If so, the burden of proof should 
be on the employee to show that the THC use was unintentional. 
CBD use should be at the sole risk of the employee.  If the employee 
is subject to Department of Transportation mandated standards, 
CBD use cannot be an acceptable justification for a positive THC 
test.  Any significantly elevated level of THC metabolite106 on a 
drug test (or evidence of actual impairment plus positive THC test) 
should be presumptive of knowing ingestion of THC.  
Employers should ensure that job descriptions accurately 
describe essential job functions and responsibilities.  If there is an 
“essential” aspect of a job which excludes medical marijuana use, 
make sure other employees in the group who are authorized to use 
medicinal THC do not perform those duties or responsibilities (e.g. 
“this task is only suitable for, and only to be performed by, non-THC 
users”).  When questions arise, consider submitting employees’ job 
descriptions to doctors or physician assistants involved in reviewing 
or certifying ADA or FMLA eligibility.  Employers should not 
hesitate to ask medical providers what specific tasks or 
responsibilities employees may safely or efficiently perform while 
using medical marijuana.  Such inquiries may also include whether 
an employee is capable of working overtime or rotating shifts.  If a 
specific job duty is essential to the employer’s mission, make sure 
that is expressly noted in the job description.  
106. Fifteen or more nanograms of THC metabolite per milliliter of urine is
a typical industry screening standard.  See Kulig, supra note 82, at 107. 
